Fate of oral enzymes in pancreatic insufficiency.
Oral pancreatic enzyme supplements, including those protected from gastric acidity by enteric coating, often achieve only partial correction of pancreatic steatorrhoea. To characterise the mechanisms involved in vivo, eight patients with steatorrhoea due to advanced pancreatic insufficiency and nine healthy controls were studied. Two sets of studies (small bowel intubation and five day faecal fat quantification) were randomly performed while patients were either on enteric coated pancreatin or equivalent placebo. A 260 cm long multilumen tube was used for double marker perfusion of two 20 cm segments located in the duodenum and in the ileum respectively. Luminal pH, flow, and trypsin and lipase activity outputs were measured at each segment for four hours postcibally. Placebo treated patients with pancreatic steatorrhoea had low enzyme outputs in the duodenal test segment and even lower outputs in the ileal segment. Pancreatin treatment significantly decreased steatorrhoea (p < 0.05) and increased luminal enzyme outputs (p < 0.05). The increase was much greater in the ileal than in the duodenal segment. Thus enteric coated pancreatin treatment abolished the normal gradient between postcibal duodenal and ileal lipase output. The results suggest that enteric coated pancreatin nearly corrects severe pancreatic steatorrhoea. The ingested lipase was utilised inefficiently, however, as luminal enzyme activity in the ileum was enhanced to a greater extent than in the duodenum, and consequently the absorptive potential of the small bowel was only partially utilised.
Digestive System Research Unit, Hospital General Vall d'Hebron, Autonomous University of Barcelona, Spain.
L
L
Guarner
R
R
Rodríguez
F
F
Guarner
J R
JR
Malagelada
D002446:Celiac Disease / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D003692:Delayed-Action Preparations; D004386:Duodenum / Q000201:enzymology; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D005243:Feces / Q000737:chemistry; D005260:Female; D006801:Humans; D007082:Ileum / Q000201:enzymology; D007421:Intestine, Small / Q000378:metabolism*; D008049:Lipase / Q000378:metabolism; D008055:Lipids / Q000032:analysis; D008297:Male; D010194:Pancreatin / Q000008:administration & dosage*; D014357:Trypsin / Q000378:metabolism
D003692:Delayed-Action Preparations; D008055:Lipids; D010194:Pancreatin; D008049:Lipase; D014357:Trypsin